Modified 5-fluorouracil: Uridine phosphorylase inhibitor
- 作者: Lashkov A.A.1, Shchekotikhin A.A.2, Shtil A.A.3, Sotnichenko S.E.1, Mikhailov A.M.1
-
隶属关系:
- Shubnikov Institute of Crystallography of Federal Scientific Research Centre “Crystallography and Photonics”
- Gause Institute of New Antibiotics
- Blokhin Russian Cancer Research Center
- 期: 卷 61, 编号 5 (2016)
- 页面: 826-829
- 栏目: Structure of Macromolecular Compounds
- URL: https://journals.rcsi.science/1063-7745/article/view/190309
- DOI: https://doi.org/10.1134/S1063774516050138
- ID: 190309
如何引用文章
详细
5-Fluorouracil (5-FU) is a medication widely used in chemotherapy to treat various types of cancer. Being a substrate for the reverse reaction catalyzed by uridine phosphorylase (UPase), 5-FU serves as a promising prototype molecule (molecular scaffold) for the design of a selective UPase inhibitor that enhances the antitumor activity of 5-FU and exhibits intrinsic cytostatic effects on cancer cells. The chemical formula of the new compound, which binds to the uracil-binding site and, in the presence of a phosphate anion, to the phosphate-binding site of UPase, is proposed and investigated by molecular simulation methods.
作者简介
A. Lashkov
Shubnikov Institute of Crystallography of Federal Scientific Research Centre “Crystallography and Photonics”
编辑信件的主要联系方式.
Email: alashkov83@gmail.com
俄罗斯联邦, Leninskii pr. 59, Moscow, 119333
A. Shchekotikhin
Gause Institute of New Antibiotics
Email: alashkov83@gmail.com
俄罗斯联邦, ul. Bol’shaya Pirogovskaya 11, Moscow, 119021
A. Shtil
Blokhin Russian Cancer Research Center
Email: alashkov83@gmail.com
俄罗斯联邦, Kashirskoe sh. 23, Moscow, 115478
S. Sotnichenko
Shubnikov Institute of Crystallography of Federal Scientific Research Centre “Crystallography and Photonics”
Email: alashkov83@gmail.com
俄罗斯联邦, Leninskii pr. 59, Moscow, 119333
A. Mikhailov
Shubnikov Institute of Crystallography of Federal Scientific Research Centre “Crystallography and Photonics”
Email: alashkov83@gmail.com
俄罗斯联邦, Leninskii pr. 59, Moscow, 119333
补充文件
